Need for lmmunologic Stimulators During lmrnunosuppression Produced by Major Cancer Surgery
Open Access
- 1 July 1985
- journal article
- review article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 202 (1) , 9-20
- https://doi.org/10.1097/00000658-198507000-00002
Abstract
Although surgery, radiology, and anticancer chemicals have been effective in the treatment of cancer, the immunologic phase of therapy deserves more effort and thought, because the possibilities are considerable. However, the immunologic phase is so complicated that, without the advances made during the past few years, little could be expected from immunology. The focus of this paper is on the immunosuppression produced by major cancer operations, at which time the patient needs immunologic help.Keywords
This publication has 84 references indexed in Scilit:
- Effects of tumor growth on interleukins and circulating immune complexes. Mechanisms of immune unresponsivenessCancer, 1984
- Phase I study of the adoptive immunotherapy of human cancer with lectin activated autologous mononuclear cellsCancer, 1984
- Immunosuppressive acidic protein in patients with ovarian cancerCancer, 1983
- Preliminary Observations of the Effects on Breast Adenocarcinoma of Plasma Perfused over Immobilized Protein ANew England Journal of Medicine, 1981
- T cell-mediated immunosuppression as an obstacle to adoptive immunotherapy of the P815 mastocytoma and its metastases.The Journal of Experimental Medicine, 1981
- Cancer in patients treated with immunosuppressive drugs.BMJ, 1981
- Anesthesia and Surgery: A Double‐Edged Sword for the Cancer PatientJournal of Surgical Oncology, 1980
- Ultrasound: A new immunosuppressantClinical Immunology and Immunopathology, 1979
- BCG lmmunotherapy of Malignant MelanomaAnnals of Surgery, 1974
- Implantation of tumor cells as a factor in recurrence of carcinoma of the rectosigmoid.Report of four cases with implantation at dentate lineCancer, 1955